Cargando…
Identification of a proliferator-activated receptor-γ antagonist for the treatment of type 2 diabetes mellitus
In the present study, a novel antagonist of the peroxisome proliferator-activated receptor-γ (PPARγ) was screened and identified, and a cell-based evaluation of the biological activity of this PPARγ antagonist was conducted. The aim of the study was to produce results that may provide a foundation f...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280942/ https://www.ncbi.nlm.nih.gov/pubmed/25574213 http://dx.doi.org/10.3892/etm.2014.2096 |